Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI111903

Influence of naloxone on the total capacitance vasculature of the dog.

L Bell, E Maratea, and D L Rutlen

Find articles by Bell, L. in: PubMed | Google Scholar

Find articles by Maratea, E. in: PubMed | Google Scholar

Find articles by Rutlen, D. in: PubMed | Google Scholar

Published June 1, 1985 - More info

Published in Volume 75, Issue 6 on June 1, 1985
J Clin Invest. 1985;75(6):1894–1903. https://doi.org/10.1172/JCI111903.
© 1985 The American Society for Clinical Investigation
Published June 1, 1985 - Version history
View PDF
Abstract

The opiate antagonist, naloxone, which is associated with prolonged survival in animal models of shock, has been demonstrated to increase arterial pressure and cardiac output. It is possible that the increase in cardiac output is due to a decrease in volume in the total capacitance vasculature and a subsequent increase in venous return. Because the influence of naloxone on the capacitance vasculature is unknown, the present study was undertaken to determine the influence of naloxone on intravascular volume in the total capacitance circulation. In 31 anesthetized dogs, blood from the vena cavae was drained into an extracorporeal reservoir and returned to the right atrium at a constant rate so that changes in total intravascular volume could be measured as reciprocal changes in reservoir volume. In five animals, naloxone infusion (2 mg/ml X min for 20 min) was associated with a decrease in total capacitance volume of 121 +/- 30 ml (P less than 0.05). To determine regional volume effects, naloxone was infused in 11 animals in which the splanchnic and extrasplanchnic vasculatures were separately perfused and drained: total and splanchnic volume decreased 64 +/- 13 ml (P less than 0.05) and 126 +/- 17 ml (P less than 0.0001), respectively, and extrasplanchnic volume increased 62 +/- 13 ml (P less than 0.001). After ganglionic blockade with mecamylamine (n = 3), total volume decreased 89 +/- 16 ml (P less than 0.05), splanchnic volume did not change, and extrasplanchnic volume decreased 91 +/- 32 ml (P less than 0.05). In another five animals, naloxone was infused during diversion of the splanchnic venous outflow to a nonrecirculating extracorporeal reservoir: total volume decreased 122 +/- 33 ml (P less than 0.05), splanchnic volume did not change, and extrasplanchnic volume decreased 101 +/- 16 ml (P less than 0.01). When the splanchnic venous effluent was reinfused without naloxone administration (n = 4), total volume decreased 43 +/- 5 ml (P less than 0.05), splanchnic volume decreased 113 +/- 14 ml (P less than 0.05), and extrasplanchnic volume increased 68 +/- 10 ml (P less than 0.05). Thus, naloxone is associated with a decrease in total capacitance volume, which is due entirely to a decrease in splanchnic volume. The splanchnic volume decrement would appear to be mediated through neurogenic and hormonal influences. In an animal not on bypass, it would be expected that naloxone would be associated with a decrease in total capacitance volume and subsequent increases in venous return and cardiac output.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1894
page 1894
icon of scanned page 1895
page 1895
icon of scanned page 1896
page 1896
icon of scanned page 1897
page 1897
icon of scanned page 1898
page 1898
icon of scanned page 1899
page 1899
icon of scanned page 1900
page 1900
icon of scanned page 1901
page 1901
icon of scanned page 1902
page 1902
icon of scanned page 1903
page 1903
Version history
  • Version 1 (June 1, 1985): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts